THE GROWING THREAT OF CARBAPENEM AND CEPHALOSPORIN RESISTANCE: ANTIMICROBIAL RESISTANCE PATTERNS OF WHO PRIORITY PATHOGENS IN A TERTIARY CARE SETTING
DOI:
https://doi.org/10.55519/JAMC-01-14380Keywords:
Antimicrobial resistance; WHO priority pathogens; Carbapenem resistance; Cephalosporin resistance; Pakistan; Hospital surveillanceAbstract
Background: Antimicrobial resistance is an increasing global health issue with increased resistance to carbapenems and cephalosporins among WHO priority pathogens, particularly in low- and middle-income countries like Pakistan. The current study aimed to analyze the prevalence and resistance patterns of selected WHO Priority Pathogens at Saidu Teaching Hospital, SWAT, Pakistan.
References
1. O’Brien TF, Clark A, Peters R, Stelling J. Why surveillance of antimicrobial resistance needs to be automated and
comprehensive. Journal of Global Antimicrobial Resistance. 2019 Jun 1;17:8–15.
2. Pormohammad A, Nasiri MJ, Azimi T. Prevalence of antibiotic resistance in Escherichia coli strains
simultaneously isolated from humans, animals, food, and the environment: a systematic review and meta-analysis.
Infection and Drug Resistance. 2019 May 8;12:1181–97.
3. Sharahi JY, Azimi T, Shariati A, Safari H, Tehrani MK, Hashemi A. Advanced strategies for combating bacterial
biofilms. Journal Cellular Physiology. 2019 Sep;234(9):14689–708.
4. Azimi T, Nasiri MJ, Zamani S, Hashemi A, Goudarzi H, Fooladi AAI, et al. High genetic diversity among
Mycobacterium tuberculosis strains in Tehran, Iran. Journal of Clinical Tuberculosis and Other Mycobacterial Diseases.
2018 May 1;11:1–6.
5. Shariati A, Azimi T, Ardebili A, Chirani AS, Bahramian A, Pormohammad A, et al. Insertional inactivation of oprD in
carbapenem-resistant Pseudomonas aeruginosa strains isolated from burn patients in Tehran, Iran. New Microbes
and New Infections. 2018 Jan 1;21:75–80.
6. Tian L, Sun Z, Zhang Z. Antimicrobial resistance of pathogens causing nosocomial bloodstream infection in
Hubei Province, China, from 2014 to 2016: a multicenter retrospective study. BMC Public Health. 2018 Sep
15;18(1):1121.
Maraki S, Mantadakis E, Mavromanolaki VE, Kofteridis DP, Samonis G. A 5-year Surveillance Study on Antimicrobial
Resistance of Acinetobacter baumannii Clinical Isolates from a Tertiary Greek Hospital. Infect Chemother. 2016 Sep
9;48(3):190–8.
Kang CI, Song JH. Antimicrobial Resistance in Asia: Current Epidemiology and Clinical Implications. Infect
Chemother. 2013;45(1):22.
9. Abrar S, Hussain S, Khan RA, Ul Ain N, Haider H, Riaz S. Prevalence of extended-spectrum-β-lactamase-producing
Enterobacteriaceae: first systematic meta-analysis report from Pakistan. Antimicrob Resist Infect Control. 2018 Feb
20;7(1):26.
10. Yasmin F, Akhtar N, Hameed A. In vitro synergistic effect of ciprofloxacin with aminoglycosides against multidrug
resistant-Pseudomonas aeruginosa. Pakistan Journal of Pharmaceutical Sciences. 2013 Sep 1;26(5):1041–5.
11. Qamar FN, Yousafzai MT, Khalid M, Kazi AM, Lohana H, Karim S, et al. Outbreak investigation of ceftriaxoneresistant Salmonella enterica serotype Typhi and its risk factors among the general population in Hyderabad,
Pakistan: a matched case-control study. The Lancet Infectious Diseases. 2018 Dec 1;18(12):1368–76.
12. Shahla L, M. Saeed A, Ishtiaq A. Bacterial pathogens responsible for blood stream infection [BSI] and pattern of
drug resistance in a tertiary care hospital of Lahore. 2009;101–5.
13. Kaleem F, Usman J, Hassan A, Khan A. Frequency and susceptibility pattern of metallo-beta-lactamase producers in
a hospital in Pakistan. The Journal of Infection in Developing Countries. 2010 Dec 21;4(12):810–3.
14. Zilberberg MD, Kollef MH, Shorr AF. Secular trends in Acinetobacter baumannii resistance in respiratory and blood
stream specimens in the United States, 2003 to 2012: A survey study. Journal of Hospital Medicine. 2016
Jan;11(1):21–6.
15. Nasser A, Moradi M, Jazireian P, Safari H, Alizadeh-Sani M, Pourmand MR, et al. Staphylococcus aureus versus
neutrophil: Scrutiny of ancient combat. Microbial Pathogenesis. 2019 Jun;131:259–69.
16. Tsutsui A, Suzuki S. Japan nosocomial infections surveillance (JANIS): a model of sustainable national
antimicrobial resistance surveillance based on hospital diagnostic microbiology laboratories. BMC Health Serv Res.
2018 Dec;18(1):799.
17. WHO. WHO. Global action plan on antimicrobial resistance [Internet]. 2015. Available from:
http://www.who.int/antimicrobial-resistance/global-actionplan/en/18. WHO. GLASS report: early implementation 2017-2018
[Internet]. [cited 2025 Feb 2]. Available from: https://www.who.int/publications/i/item/9789241515061
19. Li L, Dai J xi, Xu L, Chen Z hong, Li X yi, Liu M, et al. Antimicrobial resistance and pathogen distribution in
hospitalized burn patients: A multicenter study in Southeast China. Medicine. 2018 Aug;97(34):e11977.
20. WHO. Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug
resistant bacterial infections [Internet]. 2017. Available from: https://www.who.int/medicines/areas/rational_use/prioritizati
on-ofpathogens/en/.
21. Bonomo RA, Burd EM, Conly J, Limbago BM, Poirel L, Segre JA, et al. Carbapenemase-Producing Organisms: A
Global Scourge. Clinical Infectious Diseases. 2018 Apr 3;66(8):1290–7.
22. Zanichelli V, Huttner A, Harbarth S, Kronenberg A, Huttner B, Swiss Centre for Antibiotic Resistance Anresis.
Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates
from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009–
2016). Swiss Med Wily [Internet]. 2019 Jul 24 [cited 2025 Feb 3]; Available from: https://smw.ch/index.php/smw/article/view/2648
23. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical Practice Guidelines by the
Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in
Adults and Children. Clinical Infectious Diseases. 2011 Feb 1;52(3):e18–55.
24. Pitout JDD, Peirano G, Matsumura Y, DeVinney R, Chen L. Escherichia coli sequence type 410 with carbapenemases: a
paradigm shift within E. coli toward multidrug resistance. Tamma PD, editor. Antimicrob Agents Chemother. 2024 Feb
7;68(2):e01339-23.
25. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development
of new antibiotics: the WHO priority list of antibioticresistant bacteria and tuberculosis. The Lancet Infectious
Diseases. 2018 Mar 1;18(3):318–27.
26. Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, Van Duin D, Clancy CJ. Infectious Diseases Society of America
Guidance on the Treatment of AmpC β-Lactamase–Producing Enterobacterales, Carbapenem-Resistant
Acinetobacter baumannii , and Stenotrophomonas maltophilia Infections. Clinical Infectious Diseases. 2022 Jul
6;74(12):2089–114.
27. Jiang Y, Ding Y, Wei Y, Jian C, Liu J, Zeng Z. Carbapenemresistant Acinetobacter baumannii: A challenge in the
intensive care unit. Front Microbiol. 2022 Nov 10;13:1045206.
28. Chen PY, Chuang YC, Wang JT, Sheng WH, Chen YC, Chang SC. Predictors for vancomycin resistant Enterococcus
faecium transforming from colonization to infection: a case control study. Antimicrob Resist Infect Control. 2019
Dec;8(1):196.
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Irshad Ali, Safina Mufti, Noreen Taj, Muhammad Ashfaq, Muhammad Junaid Hassan Sharif, Qasim Khan, Syed Mobasher Ali Abid
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Journal of Ayub Medical College, Abbottabad is an OPEN ACCESS JOURNAL which means that all content is FREELY available without charge to all users whether registered with the journal or not. The work published by J Ayub Med Coll Abbottabad is licensed and distributed under the creative commons License CC BY ND Attribution-NoDerivs. Material printed in this journal is OPEN to access, and are FREE for use in academic and research work with proper citation. J Ayub Med Coll Abbottabad accepts only original material for publication with the understanding that except for abstracts, no part of the data has been published or will be submitted for publication elsewhere before appearing in J Ayub Med Coll Abbottabad. The Editorial Board of J Ayub Med Coll Abbottabad makes every effort to ensure the accuracy and authenticity of material printed in J Ayub Med Coll Abbottabad. However, conclusions and statements expressed are views of the authors and do not reflect the opinion/policy of J Ayub Med Coll Abbottabad or the Editorial Board.
USERS are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.
AUTHORS retain the rights of free downloading/unlimited e-print of full text and sharing/disseminating the article without any restriction, by any means including twitter, scholarly collaboration networks such as ResearchGate, Academia.eu, and social media sites such as Twitter, LinkedIn, Google Scholar and any other professional or academic networking site.
